San Clemente, Calif.
Delivering bradycardia pacing therapy without placing an implant within or on the heart
AtaCor Medical is developing novel cardiac pacing therapies that do not require the placement of any hardware inside or onto a person’s heart. The technology has already completed early clinical evaluation and will offer an important alternative treatment option for patients requiring bradycardia pacing support, according to the company.
The company announced in April that it had closed a $25 million Series B funding round. –TS
Investors include: Catalyst Health Ventures, Hatteras Venture Partners, aMoon Fund, Broadview Ventures, Lymo Ventures